Article info

Download PDFPDF
Concise report
High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block

Authors

  • Anna R Lisney Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany German Rheumatism Research Center Berlin (DRFZ), Berlin, Germany PubMed articlesGoogle scholar articles
  • Franziska Szelinski Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Karin Reiter Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Gerd R Burmester Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany PubMed articlesGoogle scholar articles
  • Thomas Rose Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany German Rheumatism Research Center Berlin (DRFZ), Berlin, Germany PubMed articlesGoogle scholar articles
  • Thomas Dörner Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Berlin, Germany German Rheumatism Research Center Berlin (DRFZ), Berlin, Germany PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Thomas Dörner, Department of Rheumatology and Clinical Immunology, Charité Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany; thomas.doerner{at}charite.de
View Full Text

Citation

Lisney AR, Szelinski F, Reiter K, et al
High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type I interferon signature is a risk factor for the development of autoimmune congenital heart block

Publication history

  • Received December 6, 2016
  • Revised March 10, 2017
  • Accepted April 9, 2017
  • First published May 13, 2017.
Online issue publication 
July 11, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.